FBRX: Forte Biosciences Inc Amount of Cash per Share

Forte Biosciences, Inc. - graphic logo of issuer FBRX

Forte Biosciences, Inc. (FBRX) is mitigating pipeline risks through multidisciplinary research into dermatological agents, leveraging an innovation cycle that remains independent of macroeconomic trends. The average cash per share serves as a resilience indicator, where the value 9.36 captures the current metric level. The potential for stable sales is underpinned by the constant patient demand for chronic skin disease therapies.

FBRX - Forte Biosciences, Inc Cash per Share over the range 07/04/2022 - 09/06/2026

Analytical breakdowns for Forte Biosciences, Inc.

- market price and analyst price targets:
- cash availability and cash flow indicators:
Summary company analysis:FBRX Forte Biosciences, Inc
Original product of Forte Biosciences

This indicator determines the volume of liquid assets per security, allowing for an assessment of the issuer's financial stability and the risk of cash flow gaps. By analyzing the cash per share trend, an investor can forecast the ability of Forte Biosciences, Inc. (FBRX) to sustain costs for the clinical validation of therapeutic molecules without the urgent need to raise additional capital.